These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27672219)

  • 1. Glomerular Diseases: Registries and Clinical Trials.
    Moxey-Mims MM; Flessner MF; Holzman L; Kaskel F; Sedor JR; Smoyer WE; Thompson AM; Yao L
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2234-2243. PubMed ID: 27672219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.
    Mariani LH; Bomback AS; Canetta PA; Flessner MF; Helmuth M; Hladunewich MA; Hogan JJ; Kiryluk K; Nachman PH; Nast CC; Rheault MN; Rizk DV; Trachtman H; Wenderfer SE; Bowers C; Hill-Callahan P; Marasa M; Poulton CJ; Revell A; Vento S; Barisoni L; Cattran D; D'Agati V; Jennette JC; Klein JB; Laurin LP; Twombley K; Falk RJ; Gharavi AG; Gillespie BW; Gipson DS; Greenbaum LA; Holzman LB; Kretzler M; Robinson B; Smoyer WE; Guay-Woodford LM;
    Am J Kidney Dis; 2019 Feb; 73(2):218-229. PubMed ID: 30420158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of mycophenolic acid in non-transplant renal diseases.
    Stassen PM; Kallenberg CG; Stegeman CA
    Nephrol Dial Transplant; 2007 Apr; 22(4):1013-9. PubMed ID: 17307748
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary glomerular disease: to treat or not to treat.
    Donadio JV
    Contrib Nephrol; 1982; 33():86-103. PubMed ID: 7116871
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial.
    Bomback AS; Canetta PA; Beck LH; Ayalon R; Radhakrishnan J; Appel GB
    Am J Nephrol; 2012; 36(1):58-67. PubMed ID: 22722778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell suppression in primary glomerular disease.
    Rood IM; Hofstra JM; Deegens JK; Wetzels JF
    Adv Chronic Kidney Dis; 2014 Mar; 21(2):166-81. PubMed ID: 24602466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney disease trials for the 21st century: innovations in design and conduct.
    Herrington WG; Staplin N; Haynes R
    Nat Rev Nephrol; 2020 Mar; 16(3):173-185. PubMed ID: 31673162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal and Demographic Trends in Glomerular Disease Epidemiology in the Southeastern United States, 1986-2015.
    O'Shaughnessy MM; Hogan SL; Poulton CJ; Falk RJ; Singh HK; Nickeleit V; Jennette JC
    Clin J Am Soc Nephrol; 2017 Apr; 12(4):614-623. PubMed ID: 28325866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American Society of Nephrology quiz and questionnaire 2013: glomerulonephritis.
    Fervenza FC; Perazella MA; Choi MJ
    Clin J Am Soc Nephrol; 2014 May; 9(5):987-96. PubMed ID: 24578330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular disease: why is there a dearth of high quality clinical trials?
    Leaf DE; Appel GB; Radhakrishnan J
    Kidney Int; 2010 Aug; 78(4):337-42. PubMed ID: 20520593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of glomerular diseases in Taiwan: preliminary report of National Renal Biopsy Registry-publication on behalf of Taiwan Society of Nephrology.
    Chiu HF; Chen HC; Lu KC; Shu KH;
    BMC Nephrol; 2018 Jan; 19(1):6. PubMed ID: 29320993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil treatment for primary glomerular diseases.
    Choi MJ; Eustace JA; Gimenez LF; Atta MG; Scheel PJ; Sothinathan R; Briggs WA
    Kidney Int; 2002 Mar; 61(3):1098-114. PubMed ID: 11849465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease.
    Carter SA; Lightstone L; Cattran D; Bagga A; Barbour SJ; Barratt J; Boletis J; Caster D; Coppo R; Fervenza FC; Floege J; Hladunewich M; Hogan JJ; Kitching AR; Lafayette R; Malvar A; Radhakrishnan J; Rovin BH; Zhang H; Gutman T; Howell M; Logeman C; Shen JI; Teixeira-Pinto A; Alexander SI; Cho Y; Craig JC; Harris D; Johnson DW; Kerr PG; Ryan J; Viecelli AK; Wang AY; Wilkie M; Scholes-Robertson N; Tong A;
    Kidney Int; 2019 Jun; 95(6):1280-1283. PubMed ID: 31122702
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppressive treatment in the prevention of renal failure in primary glomerular diseases.
    Glassock RJ
    Clin Exp Dial Apheresis; 1981; 5(1-2):21-46. PubMed ID: 7037247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Risk of Cardiovascular Events in Individuals With Primary Glomerular Diseases.
    Canney M; Gunning HM; Zheng Y; Rose C; Jauhal A; Hur SA; Sahota A; Reich HN; Barbour SJ
    Am J Kidney Dis; 2022 Dec; 80(6):740-750. PubMed ID: 35659570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic tests and treatment options in glomerular disease: 2014 update.
    Hogan J; Mohan P; Appel GB
    Am J Kidney Dis; 2014 Apr; 63(4):656-66. PubMed ID: 24239051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome.
    Zietse R; Wenting GJ; Kramer P; Schalekamp MA; Weimar W
    Clin Sci (Lond); 1992 Jun; 82(6):641-50. PubMed ID: 1320544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach.
    Gadegbeku CA; Gipson DS; Holzman LB; Ojo AO; Song PX; Barisoni L; Sampson MG; Kopp JB; Lemley KV; Nelson PJ; Lienczewski CC; Adler SG; Appel GB; Cattran DC; Choi MJ; Contreras G; Dell KM; Fervenza FC; Gibson KL; Greenbaum LA; Hernandez JD; Hewitt SM; Hingorani SR; Hladunewich M; Hogan MC; Hogan SL; Kaskel FJ; Lieske JC; Meyers KE; Nachman PH; Nast CC; Neu AM; Reich HN; Sedor JR; Sethna CB; Trachtman H; Tuttle KR; Zhdanova O; Zilleruelo GE; Kretzler M
    Kidney Int; 2013 Apr; 83(4):749-56. PubMed ID: 23325076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.